v3.26.1
Centre Lane Senior Secured Credit Facility - Schedule of Amendments in Line of Credit Facilities (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Sep. 30, 2025
Line of Credit Facility [Line Items]      
Draw $ 39,852    
Amendment Fee $ 4,987    
Common Stock Issued (in shares) 47,679,827    
First Amendment      
Line of Credit Facility [Line Items]      
Draw Date Apr. 26, 2021    
Draw $ 0    
Repayment Date Dec. 20, 2026    
Interest Rate Paid-in-Kind 8.00%    
Interest Rate Cash 0.00%    
Amendment Fee $ 0    
Common Stock Issued (in shares) 150,000    
Accounting Impact Extinguishment    
Second Amendment      
Line of Credit Facility [Line Items]      
Draw Date May 26, 2021    
Draw $ 1,500    
Repayment Date Dec. 20, 2026    
Interest Rate Paid-in-Kind 8.00%    
Interest Rate Cash 0.00%    
Amendment Fee $ 750    
Common Stock Issued (in shares) 3,000,000    
Accounting Impact Modification    
Third Amendment      
Line of Credit Facility [Line Items]      
Draw Date Aug. 12, 2021    
Draw $ 500    
Repayment Date Dec. 20, 2026    
Interest Rate Paid-in-Kind 8.00%    
Interest Rate Cash 0.00%    
Amendment Fee $ 250    
Common Stock Issued (in shares) 2,000,000    
Accounting Impact Modification    
Fourth Amendment      
Line of Credit Facility [Line Items]      
Draw Date Aug. 31, 2021    
Draw $ 1,100    
Repayment Date Dec. 20, 2026    
Interest Rate Paid-in-Kind 8.00%    
Interest Rate Cash 0.00%    
Amendment Fee $ 550    
Common Stock Issued (in shares) 0    
Accounting Impact Modification    
Fifth Amendment      
Line of Credit Facility [Line Items]      
Draw Date Oct. 08, 2021    
Draw $ 725    
Repayment Date Dec. 20, 2026    
Interest Rate Paid-in-Kind 8.00%    
Interest Rate Cash 0.00%    
Amendment Fee $ 363    
Common Stock Issued (in shares) 0    
Accounting Impact Extinguishment    
Sixth Amendment      
Line of Credit Facility [Line Items]      
Draw Date Nov. 05, 2021    
Draw $ 800    
Repayment Date Dec. 20, 2026    
Interest Rate Paid-in-Kind 8.00%    
Interest Rate Cash 0.00%    
Amendment Fee $ 800    
Common Stock Issued (in shares) 7,500,000    
Accounting Impact Modification    
Seventh Amendment      
Line of Credit Facility [Line Items]      
Draw Date Dec. 23, 2021    
Draw $ 500    
Repayment Date Dec. 20, 2026    
Interest Rate Paid-in-Kind 8.00%    
Interest Rate Cash 0.00%    
Amendment Fee $ 500    
Common Stock Issued (in shares) 0    
Accounting Impact Modification    
Amendment One through Seven      
Line of Credit Facility [Line Items]      
Draw $ 5,125    
Amendment Fee $ 3,213    
Common Stock Issued (in shares) 12,650,000    
Eighth Amendment      
Line of Credit Facility [Line Items]      
Draw Date Jan. 26, 2022    
Draw $ 350    
Repayment Date Dec. 20, 2026    
Interest Rate Paid-in-Kind 8.00%    
Interest Rate Cash 0.00%    
Amendment Fee $ 350    
Common Stock Issued (in shares) 0    
Accounting Impact Modification    
Ninth Amendment      
Line of Credit Facility [Line Items]      
Draw Date Feb. 11, 2022    
Draw $ 250    
Repayment Date Dec. 20, 2026    
Interest Rate Paid-in-Kind 0.00%    
Interest Rate Cash 7.00%    
Amendment Fee $ 13    
Common Stock Issued (in shares) 0    
Accounting Impact Modification    
Tenth Amendment      
Line of Credit Facility [Line Items]      
Draw Date Mar. 11, 2022    
Draw $ 300    
Repayment Date Dec. 20, 2026    
Interest Rate Paid-in-Kind 0.00%    
Interest Rate Cash 7.00%    
Amendment Fee $ 15    
Common Stock Issued (in shares) 0    
Accounting Impact Modification    
Eleventh Amendment      
Line of Credit Facility [Line Items]      
Draw Date Mar. 25, 2022    
Draw $ 500    
Repayment Date Dec. 20, 2026    
Interest Rate Paid-in-Kind 0.00%    
Interest Rate Cash 7.00%    
Amendment Fee $ 25    
Common Stock Issued (in shares) 0    
Accounting Impact Modification    
Twelveth Amendment      
Line of Credit Facility [Line Items]      
Draw Date Apr. 15, 2022    
Draw $ 450    
Repayment Date Dec. 20, 2026    
Interest Rate Paid-in-Kind 0.00%    
Interest Rate Cash 7.00%    
Amendment Fee $ 23    
Common Stock Issued (in shares) 0    
Accounting Impact Modification    
Thirteenth Amendment      
Line of Credit Facility [Line Items]      
Draw Date May 10, 2022    
Draw $ 500    
Repayment Date Dec. 20, 2026    
Interest Rate Paid-in-Kind 0.00%    
Interest Rate Cash 7.00%    
Amendment Fee $ 25    
Common Stock Issued (in shares) 0    
Accounting Impact Modification    
Fourteenth Amendment      
Line of Credit Facility [Line Items]      
Draw Date Jun. 10, 2022    
Draw $ 350    
Repayment Date Dec. 20, 2026    
Interest Rate Paid-in-Kind 0.00%    
Interest Rate Cash 7.00%    
Amendment Fee $ 18    
Common Stock Issued (in shares) 0    
Accounting Impact Modification    
Fifteenth Amendment      
Line of Credit Facility [Line Items]      
Draw Date Jul. 08, 2022    
Draw $ 350    
Repayment Date Dec. 20, 2026    
Interest Rate Paid-in-Kind 0.00%    
Interest Rate Cash 7.00%    
Amendment Fee $ (58)    
Common Stock Issued (in shares) 0    
Accounting Impact Modification    
Amendment Eight through Fifteen      
Line of Credit Facility [Line Items]      
Draw $ 3,050    
Amendment Fee $ 411    
Common Stock Issued (in shares) 0    
Sixteenth Amendment      
Line of Credit Facility [Line Items]      
Draw Date Feb. 10, 2023    
Draw $ 1,500    
Repayment Date Dec. 20, 2026    
Interest Rate Paid-in-Kind 0.00%    
Interest Rate Cash 7.00%    
Amendment Fee $ 75    
Common Stock Issued (in shares) 0    
Accounting Impact Modification    
Seventeenth Amendment      
Line of Credit Facility [Line Items]      
Draw Date Apr. 20, 2023    
Draw $ 26,316    
Repayment Date Dec. 20, 2026    
Interest Rate Paid-in-Kind 15.00%    
Interest Rate Cash 0.00%    
Amendment Fee $ 708    
Common Stock Issued (in shares) 21,401,993    
Accounting Impact Extinguishment    
Nineteenth Amendment      
Line of Credit Facility [Line Items]      
Draw Date Jul. 08, 2023    
Draw $ 2,000    
Repayment Date Dec. 31, 2024    
Interest Rate Paid-in-Kind 0.00%    
Interest Rate Cash 7.00%    
Amendment Fee $ 100    
Common Stock Issued (in shares) 0    
Accounting Impact Modification    
Amendment Sixteen Through Nineteen      
Line of Credit Facility [Line Items]      
Draw $ 29,816    
Amendment Fee $ 883    
Common Stock Issued (in shares) 21,401,993    
Twentieth Amendment      
Line of Credit Facility [Line Items]      
Draw Date Jun. 05, 2024    
Draw $ 0    
Repayment Date Dec. 20, 2026    
Interest Rate Paid-in-Kind 0.00%    
Interest Rate Cash 0.00%    
Amendment Fee $ 472    
Common Stock Issued (in shares) 0    
Accounting Impact Modification    
Twentyone Amendment      
Line of Credit Facility [Line Items]      
Draw Date Dec. 26, 2024    
Draw $ 1,861    
Repayment Date Dec. 20, 2026    
Interest Rate Paid-in-Kind 15.00%    
Interest Rate Cash 0.00%    
Amendment Fee $ 0    
Common Stock Issued (in shares) 5,001,991    
Accounting Impact Modification    
Amendment Twenty Through Twenty One      
Line of Credit Facility [Line Items]      
Draw $ 1,861    
Amendment Fee $ 472    
Common Stock Issued (in shares) 5,001,991    
Twenty Third Amendment      
Line of Credit Facility [Line Items]      
Draw Date Sep. 30, 2025    
Draw $ 0    
Repayment Date Dec. 20, 2026    
Interest Rate Paid-in-Kind 0.00%    
Interest Rate Cash 0.00%    
Amendment Fee $ 8    
Common Stock Issued (in shares) 2,832,485   2,832,485
Accounting Impact Modification    
Twenty Fourth Amendment      
Line of Credit Facility [Line Items]      
Draw Date Dec. 31, 2025    
Draw $ 0    
Repayment Date Dec. 20, 2026    
Interest Rate Paid-in-Kind 0.00%    
Interest Rate Cash 0.00%    
Amendment Fee $ 0    
Common Stock Issued (in shares) 2,870,792 2,870,792  
Accounting Impact Modification    
Amendment Twenty Third Through Twenty Four      
Line of Credit Facility [Line Items]      
Draw $ 0    
Amendment Fee $ 8    
Common Stock Issued (in shares) 5,703,277    
Twenty-Fifth Amendment      
Line of Credit Facility [Line Items]      
Draw Date Mar. 31, 2026    
Draw $ 0    
Repayment Date Dec. 20, 2026    
Interest Rate Paid-in-Kind 0.00%    
Amendment Fee $ 0    
Common Stock Issued (in shares) 2,922,566    
Accounting Impact Modification    
Amendment Twenty Five Through Twenty Five      
Line of Credit Facility [Line Items]      
Draw $ 0    
Amendment Fee $ 0    
Common Stock Issued (in shares) 2,922,566